3695 — GMO Research & AI Income Statement
0.000.00%
- ¥5bn
- ¥4bn
- ¥5bn
- 97
- 64
- 36
- 77
Annual income statement for GMO Research & AI, fiscal year end - December 31st, JPY millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 3,291 | 3,395 | 4,086 | 5,201 | 5,117 |
Cost of Revenue | |||||
Gross Profit | 1,601 | 1,586 | 1,980 | 2,464 | 2,542 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 3,090 | 3,132 | 3,734 | 4,781 | 4,685 |
Operating Profit | 201 | 263 | 353 | 420 | 432 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 201 | 240 | 385 | 458 | 428 |
Provision for Income Taxes | |||||
Net Income After Taxes | 137 | 174 | 274 | 356 | 308 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 137 | 176 | 274 | 356 | 307 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 137 | 176 | 274 | 356 | 307 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 80.7 | 108 | 168 | 218 | 192 |
Dividends per Share |